Neo Medical

HardwareVillette (Lavaux), SwitzerlandFounded 2013· One of 1733 Hardware companies tracked by AMPulse

Neo Medical develops innovative spinal implant solutions using advanced manufacturing including 3D printing.

CEO / Founder: Vincent Lefauconnier
Team Size: 51-200
Stage: Active
Total Funding: $88.6M ($68M Series B Sep 2024)
Latest Round: Series B
Key Investors: Gyrus Capital, Swisscom Ventures, Verve Ventures, 4FO, Credit Suisse Entrepreneur Capital, Boundary Holding

Technology & Products

Key Products

Spinal implants, including the Neo Universal system, utilizing advanced surface technologies and 3D printing.

Technological Advantage

Combination of traditional precision manufacturing with additive manufactured porous surfaces

Differentiation

Value Proposition

Next-generation spinal implants with advanced surface technologies and optimized geometries.

How They Differentiate

Swiss quality; innovative surface technology; focused portfolio approach

Market & Competition

Target Customers

Spine surgeons, hospitals, orthopedic distributors

Industry Verticals

Spine Surgery, Orthopedics, Medical Devices

Competitors

Medtronic, Stryker, Zimmer Biomet

Growth & Milestones

Growth Metrics

$112M total funding raised; $68M Series B in September 2024 (one of largest spine industry rounds in decade); 57 employees; Operating in US, Spain, France, Germany

Major Milestones

2014: Founded in Lausanne, Switzerland; Developed 3D printed titanium mesh cages for spine surgery; Launched ADVISE technology (force control + AR); Expanded to US, Spain, France, Germany; 2024-09: Raised $68M Series B led by Gyrus Capital

Notable Customers

Spine surgeons and hospitals globally, Healthcare systems in US, Europe

https://neo-medical.com

Funding rounds

Series B$68M2024-09Lead: Gyrus Capital · Source: Press Release
Series A$20.6M2022-02Lead: Swisscom Ventures · Source: Press Release
SeedUndisclosed2018-01Source: Crunchbase

Why this company matters

AMPulse analysis, not a company disclosure

Neo Medical develops spinal implant systems that integrate additive manufactured porous surfaces with traditional precision-machined substrates. The company's core technology centers on 3D-printed titanium mesh cages designed to promote osseointegration through optimized pore geometry and surface treatments. This hybrid approach aims to improve long-term fixation compared to fully machined or fully porous alternatives.

The product portfolio includes the Neo Universal system, which leverages metal LPBF (laser powder bed fusion) to create porous lattice structures on load-bearing implants. Neo Medical also markets ADVISE, a technology combining force-controlled surgical tools with augmented reality guidance for spinal procedures. The combination addresses both implant design and intraoperative workflow.

Target customers include spine surgeons, hospitals, and orthopedic distributors across the US and Europe. The company has established a commercial presence in the US, Spain, France, and Germany. Neo Medical competes against large orthopedic incumbents such as Medtronic, Stryker, and Zimmer Biomet, differentiating through Swiss manufacturing quality and a focused portfolio of advanced surface implants.

Neo Medical raised a $68 million Series B in September 2024, one of the largest funding rounds in the spine implant sector in the past decade, bringing total disclosed funding to $112 million. Investors include Gyrus Capital, Swisscom Ventures, and Verve Ventures. The company employs approximately 57 people and operates from its headquarters in Zurich, Switzerland.